A related study established that stimulation of mTORC1 with amino acids increases oncogenic H-Ras- but decreases K-Ras-nanoclustering via a phosphatidic acid-dependent mechanism downstream of SREBP1, with attendant consequences for spheroid growth of HRAS and KRAS mutant cancer cells [21]. The gene discussed is HRAS; the disease is cancer.